entertainment -WSS

entertainment

author：hotspot 2025-10-02 10:45:29 - browse：346

Purple AML cells in blood flow — coverage from STAT — Acute myeloid leukemia cells amid blood flow. Adobe

The Food and Drug Administration issued a change to the warning label for Legend Biotech and Janssen’s myeloma CAR-T, Carvykti or cilta-cel, adding that some secondary blood cancers have occurred following treatment for multiple myeloma with the cell therapy.

While the label means that physicians will have to have a conversation about secondary malignancies occurring after Carvykti treatment, oncologists and CAR-T experts said the label update won’t change anything about the use of Carvykti.

“I do not believe this particular change will have any bearing on patient care,” said Saad Usmani, a myeloma physician and cell therapist at Memorial Sloan Kettering who has also studied Carvykti. That’s partly because physicians already discuss the risk of second cancers due to other cancer therapies including radiation, some targeted therapies, and some chemotherapies, which are necessary in the use of CAR-T. “We do have secondary primary malignancy discussions with patients in the context of transplant and will have to do for CAR-T as well,” Usmani said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： FDA panel endorses Alnylam’s heart drug — after picking it apart

WSS

ASCO: AstraZeneca says CAR

BMI, flaws aside, is found to be useful estimate of body fat in youth

Ionis drug prevents swelling attacks due to hereditary angioedema

Shifting the focus from loneliness to social health

White House touts steps to stem shortages of cancer treatments

Pig kidney works a record two months in donated body

Wikipedia

entertainment

hotspot

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Innovation in antibiotics is ailing. 'Brain drain' may kill it

Jerome Adams on the need for new antivirals for Covid

Telehealth for opioid use disorder is lifesaving

Jerome Adams on the need for new antivirals for Covid

At ASCO, AstraZeneca reports strong data for breast cancer drug

Jerome Adams on the need for new antivirals for Covid

Will the IRA bring competition to the biologics market?

Heart attack and stroke risk calculators need revising

Woman returns to dialysis after doctors remove transplanted pig kidney

entertainment

How to increase colonoscopy rates? Looks like an AI can help

How to increase colonoscopy rates? Looks like an AI can help

New Covid vaccine is recommended for everyone 6 months or older

Private equity could exacerbate cardiology's overuse problem, experts fear

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

Woman returns to dialysis after doctors remove transplanted pig kidney

Wikipedia

hotspot

hotspot

Wikipedia